Phase 1/2a Dose Escalation Study in Participants With CLL, SLL, or NHL

Clinical trial NCT01994382 · COMPLETED

Trial details

NCT number: NCT01994382
Sponsor: Alexion Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Follicular Lymphoma (FL/Indolent NHL)Aggressive NHL (a NHL)Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL)T-cell Lymphoma (PTCL and CTCL)B-cell Non Hodgkin Lymphoma (NHL)

Start date: 2013-08-30
Primary completion: 2020-12-15
Enrollment: 260

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.